These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 16968899)

  • 1. Efficiency of T-cell receptor expression in dual-specific T cells is controlled by the intrinsic qualities of the TCR chains within the TCR-CD3 complex.
    Heemskerk MH; Hagedoorn RS; van der Hoorn MA; van der Veken LT; Hoogeboom M; Kester MG; Willemze R; Falkenburg JH
    Blood; 2007 Jan; 109(1):235-43. PubMed ID: 16968899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redirection of antileukemic reactivity of peripheral T lymphocytes using gene transfer of minor histocompatibility antigen HA-2-specific T-cell receptor complexes expressing a conserved alpha joining region.
    Heemskerk MH; Hoogeboom M; de Paus RA; Kester MG; van der Hoorn MA; Goulmy E; Willemze R; Falkenburg JH
    Blood; 2003 Nov; 102(10):3530-40. PubMed ID: 12869497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alphabeta T-cell receptor engineered gammadelta T cells mediate effective antileukemic reactivity.
    van der Veken LT; Hagedoorn RS; van Loenen MM; Willemze R; Falkenburg JH; Heemskerk MH
    Cancer Res; 2006 Mar; 66(6):3331-7. PubMed ID: 16540688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single T cell receptor-mediated recognition of an identical HIV-derived peptide presented by multiple HLA class I molecules.
    Ueno T; Tomiyama H; Takiguchi M
    J Immunol; 2002 Nov; 169(9):4961-9. PubMed ID: 12391209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reprogramming of virus-specific T cells into leukemia-reactive T cells using T cell receptor gene transfer.
    Heemskerk MH; Hoogeboom M; Hagedoorn R; Kester MG; Willemze R; Falkenburg JH
    J Exp Med; 2004 Apr; 199(7):885-94. PubMed ID: 15051765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promiscuous behavior of HPV16E6 specific T cell receptor beta chains hampers functional expression in TCR transgenic T cells, which can be restored in part by genetic modification.
    Scholten KB; Ruizendaal JJ; Graf M; Schoedl T; Kramer D; Meijer CJ; Man S; Hooijberg E
    Cell Oncol; 2010; 32(1-2):43-56. PubMed ID: 20208133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual recognition of a human cytotoxic T-cell clone for melanoma antigens.
    Kubo H; Abe J; Obata F; Nakajima H; Tsunoda M; Ogawa A; Nakayama S; Beck Y; Kohsaka T; Darrow TL; Abdel-Wahab Z; Saida T; Takiguchi M
    Cancer Res; 1996 May; 56(10):2368-74. PubMed ID: 8625313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved expression and reactivity of transduced tumor-specific TCRs in human lymphocytes by specific silencing of endogenous TCR.
    Okamoto S; Mineno J; Ikeda H; Fujiwara H; Yasukawa M; Shiku H; Kato I
    Cancer Res; 2009 Dec; 69(23):9003-11. PubMed ID: 19903853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA-transfection of γ/δ T cells with a chimeric antigen receptor or an α/β T-cell receptor: a safer alternative to genetically engineered α/β T cells for the immunotherapy of melanoma.
    Harrer DC; Simon B; Fujii SI; Shimizu K; Uslu U; Schuler G; Gerer KF; Hoyer S; Dörrie J; Schaft N
    BMC Cancer; 2017 Aug; 17(1):551. PubMed ID: 28818060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid re-expression of retrovirally introduced versus endogenous TCRs in engineered T cells after antigen-specific stimulation.
    van Loenen MM; Hagedoorn RS; de Boer R; van Egmond EH; Falkenburg JH; Heemskerk MH
    J Immunother; 2011 Mar; 34(2):165-74. PubMed ID: 21304404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of the V delta 1 variable region in the functional T-cell receptor alpha chain of a WT31+ cytotoxic T lymphocyte clone which specifically recognizes HLA-A2 molecule.
    Castelli C; Mazzocchi A; Salvi S; Anichini A; Sensi M
    Scand J Immunol; 1992 Apr; 35(4):487-94. PubMed ID: 1313600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional comparison of engineered T cells carrying a native TCR versus TCR-like antibody-based chimeric antigen receptors indicates affinity/avidity thresholds.
    Oren R; Hod-Marco M; Haus-Cohen M; Thomas S; Blat D; Duvshani N; Denkberg G; Elbaz Y; Benchetrit F; Eshhar Z; Stauss H; Reiter Y
    J Immunol; 2014 Dec; 193(11):5733-43. PubMed ID: 25362181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extensive conservation of alpha and beta chains of the human T-cell antigen receptor recognizing HLA-A2 and influenza A matrix peptide.
    Moss PA; Moots RJ; Rosenberg WM; Rowland-Jones SJ; Bodmer HC; McMichael AJ; Bell JI
    Proc Natl Acad Sci U S A; 1991 Oct; 88(20):8987-90. PubMed ID: 1833769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extensive T cell receptor cross-reactivity on structurally diverse haptenated peptides presented by HLA-A2.
    Gagnon SJ; Turner RV; Shiue MG; Damirjian M; Biddison WE
    Mol Immunol; 2006 Feb; 43(4):346-56. PubMed ID: 16310048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic TCR-MHC (self)-interactions limit the functional potential of TCR affinity-increased CD8 T lymphocytes.
    Duong MN; Erdes E; Hebeisen M; Rufer N
    J Immunother Cancer; 2019 Nov; 7(1):284. PubMed ID: 31690351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TCR reconstitution in Jurkat reporter cells facilitates the identification of novel tumor antigens by cDNA expression cloning.
    Aarnoudse CA; Krüse M; Konopitzky R; Brouwenstijn N; Schrier PI
    Int J Cancer; 2002 May; 99(1):7-13. PubMed ID: 11948485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploitation of CD3ζ to enhance TCR expression levels and antigen-specific T cell function.
    Degirmencay A; Thomas S; Holler A; Burgess S; Morris EC; Stauss HJ
    Front Immunol; 2024; 15():1386132. PubMed ID: 38873603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redirecting human T lymphocytes toward renal cell carcinoma specificity by retroviral transfer of T cell receptor genes.
    Engels B; Noessner E; Frankenberger B; Blankenstein T; Schendel DJ; Uckert W
    Hum Gene Ther; 2005 Jul; 16(7):799-810. PubMed ID: 16000062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone.
    Sensi M; Salvi S; Castelli C; Maccalli C; Mazzocchi A; Mortarini R; Nicolini G; Herlyn M; Parmiani G; Anichini A
    J Exp Med; 1993 Oct; 178(4):1231-46. PubMed ID: 8376931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide fine specificity of anti-glycoprotein 100 CTL is preserved following transfer of engineered TCR alpha beta genes into primary human T lymphocytes.
    Schaft N; Willemsen RA; de Vries J; Lankiewicz B; Essers BW; Gratama JW; Figdor CG; Bolhuis RL; Debets R; Adema GJ
    J Immunol; 2003 Feb; 170(4):2186-94. PubMed ID: 12574392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.